The acquisition advances PMI's goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond nicotine . Vectura is an inhaled drug delivery solutions provider and currently has 13 key inhaled and 11 non-inhaled products marketed by major global pharma companies. NEW YORK, September 15, 2021--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announced the closing of its acquisition of Fertin Pharma A/S ("Fertin Pharma"), a leading . Hanjaya Mandala Sampoerna Tbk. | October 27, 2021 Philip Morris International's proposed acquisition of Vectura-and its completed acquisitions of Fertin Pharma and OtiTopic-will expand product pipeline development capabilities in inhaled and oral therapeutics, as well as selfcare wellness.. Philip Morris International (PMI) has announced an unconditional offer to acquire the U.K. pharmaceutical company Vectura. Philip Morris: Reviewing Vectura And Fertin Pharma ... Navigate to item 0; Navigate to item 1; Navigate to item 2; Subscribe for the latest . The offer of $1.2bn made for Vectura Group from the UK resembles the offer for Fertin Pharma in that will add product know-how and manufacturing capabilities in a field where PM sees opportunities . On July 1, 2021, Philip Morris International, Inc. acquired life science company Fertin Pharma A/S from EQT Holdings AB and Bagger-Sorensen Group for 5.1B DKK Acquisition Highlights. Fertin Pharma A/S er en markedsledende aktør inden for produktion af nikotintyggegummi. Philip Morris International Announces Agreement To Acquire ... Philip Morris International Announces Agreement to Acquire Fertin Pharma The acquisition advances PMI's goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond nicotine Lausanne, Switzerland—July 1, 2021—Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a . Philip Morris acquires another inhaled-drug pharma firm. In a press release, Philip Morris International announced that it had entered into an agreement to acquire Fertin Pharma A/S, a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems. The move follows Philip Morris's $820m acquisition earlier this month of Fertin Pharma, a maker of nicotine chewing gum and oral drugs for pain. Philip Morris International Announces Agreement to Acquire ... July 1 (Reuters) - Philip Morris International Inc PM.N will buy nicotine gum maker Fertin Pharma from private equity firm EQT for 5.1 billion Danish Krone ($813.1 million), the cigarette maker. Fertin Pharma's products enable people to live healthier . Philip Morris International's DKK 5.1 Billion Acquisition ... LAUSANNE, Switzerland--(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Ph 2021-07-09 19:09:56. Philip Morris International Announces Agreement to Acquire Fertin Pharma. EQT Private Equity to sell Fertin Pharma to Philip Morris International - EQT Private Equity to sell Fertin Pharma, a leading specialist contract development and manufacturing organization (CDMO . Philip Morris International Announces Agreement to Acquire ... The transaction has an enterprise value of c. USD820 million and represents a significant milestone in the delivery of PMI's goal to become a majority smoke . 1, 2021-- Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately . Dubai, United Arab Emirates: Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million). Philip Morris International Inc. has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million1), from the private equity fund EQT. Philip Morris Bolsters 'Beyond Nicotine' Strategy with ... Philip Morris International Inc. announced Thursday that it has entered into an agreement to acquire Fertin Pharma A/S for an enterprise value of 5.1 billion Danish kroner or approximately $820 million.Fertin Pharma is currently owned by the global investment organization EQT and Bagger-Sorensen & Co. selskabet kosttilskud og cannabinoider, som i lighed med nikotin også leveres til brugeren gennem tyggegummi og tabletter. EQT Private Equity to sell Fertin Pharma to Philip Morris International. Philip Morris International announces agreement to acquire ... Fertin Pharma and associated companies acquired by Philip Morris International Vejle, 1 July, 2021 EQT announced today that it has agreed to sell Fertin Pharma, a specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International (PMI) (NYSE: PM). Denmark By Jenni Spinner 10-Aug-2021 - Last . EQT Private Equity to sell Fertin Pharma to Philip Morris ... In July, PMI signed an agreement to acquire Fertin Pharma. Philip Morris to acquire Fertin Pharma for $812.8m By vbandhakavi Recommended companies Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn). HMSP - PT. LAUSANNE, Switzerland--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million1). The deal is expected to close in the fourth quarter of 2021, subject to approval by the . "The acquisition of Fertin Pharma will be a significant step forward on our . Kapitalfonden EQT har solgt den danske producent af nikotintyggegummi Fertin Pharma A/S til Philip Morris International for DKK 5,1 mia. Philip Morris To Acquire Denmark's Fertin Pharma For $820 ... TMT Freepik. Philip Morris International (PMI) has signed an agreement to acquire Fertin Pharma from EQT for a total consideration of nearly $820m (kr5.1bn). Jul 2, 2021 10:12AM EDT. However, the company has begun moving toward dramatically reinventing itself as a pharmaceutical firm, most recently with the acquisition of respiratory drug developer OtiTopic. Fertin Pharma announces closing of acquisition by Philip ... LAUSANNE, Switzerland-(BUSINESS WIRE)-Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and . Philip Morris International Inc (PM.N) will buy nicotine gum maker Fertin Pharma from private equity firm EQT for 5.1 billion Danish Krone ($813.1 million), the cigarette maker said on Thursday . EQT købte i 2016 . For Philip Morris, the acquisition of OtiTopic builds on the company's recent M&A activities to bolster its 'Beyond Nicotine' program. In July, PMI acquired Switzerland-based Fertin Pharma in a deal valued at about $820 million. Fertin Pharma's products enable people to live healthier . TMT Iver. This is Philip Morris International's 2nd largest (disclosed) transaction. Philip Morris International Inc (PMI), the parent company of PT HM Sampoerna Tbk (HMSP), has secured a deal to acquire Fertin Pharma A/S for USD 820 million or equal to IDR 12 trillion. The deal would provide speed and scale in oral delivery to support the company's 2025 . The acquisition advances PMI's goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond nicotine . Update to this story: Today Philip Morris announced another acquisition that builds on its commitment to grow its smokefree sales and establish a substantial revenue base from non-nicotine products. EQT Private Equity to sell Fertin Pharma, a leading specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International for a headline Enterprise Value of DKK 5.1 billion. EQT Private Equity to sell Fertin Pharma to Philip Morris International. Philip Morris International (PMI) has agreed to acquire Fertin Pharma A/S, a Danish specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery. Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading The acquisition advances PMI's goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond nicotine . Industrial Technology Dunlop. Philip Morris International has entered into an agreement to acquire Fertin Pharma, a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK5.1 billion ($820 million). Derudover fremstiller bl.a. fertin pharma a/s ("fertin pharma"), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, today announced the closing of its acquisition by philip morris international inc. (pmi) (nyse: pm) for an enterprise value of dkk 5.1 billion (approximately usd 820 million … Fertin Pharma and associated companies acquired by Philip Morris International. EQT announced today that it has agreed to sell Fertin Pharma, a specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International (PMI) (NYSE: PM). The acquisition will be completed by the end of 2021. Relevant investments. Additionally, the company has a diverse portfolio of partnerships for drugs in clinical development. Rp 995 +10 (+1,00%) More Info! Philip Morris can leverage Fertin Pharma's oral delivery platforms to develop self-care . On September 16th, 2021, Philip Morris International (PMI) announced an unconditional offer to acquire the U.K. pharmaceutical company Vectura. Philip Morris International Inc. announced it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million). The $820-million deal, which is expected to close in fourth quarter 2021, will be a significant step in enhancing the tobacco company's smoke-free portfolio, PMI said. philip morris international announces agreement to acquire fertin pharma the acquisition advances pmi's goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond. Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million1). "The acquisition of Fertin Pharma . The deal is Philip Morris' second acquisition in the past week, after agreeing to buy nicotine gum maker Fertin Pharma for 5.1 billion Danish Krone ($812 million). Philip Morris International, the tobacco company and maker of Marlboro cigarettes, has struck a £1bn deal to buy Vectura, the British pharmaceutical company developing a pioneering inhaled . Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 . Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn). EQT Private Equity to sell Fertin Pharma, a leading specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International for a headline Enterprise Value of DKK 5.1 billion. Industrial Technology Dunlop. The U.S. company . Philip Morris expects the acquisition of Fertin Pharma to be a significant step in its smoke-free portfolio. The company aims to generate more than half of . Philip Morris to acquire Fertin Pharma to become majority smoke-free business. Founded by the Bagger-Sørensen family, Fertin Pharma develops and . JAKARTA. Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million 1). philip morris international inc. (pmi) (nyse: pm) today announced the closing of its acquisition of fertin pharma a/s ("fertin pharma"), a leading developer and manufacturer of innovative. Jacek Olczak, CEO . Vejle, 1 July, 2021. NEW YORK — Philip Morris International Inc. (PMI) has entered an agreement to acquire Fertin Pharma A/S. Fertin Pharma is a privately held . LAUSANNE, Switzerland--(BUSINESS WIRE)-- Philip Morris International Inc. (PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being . With headquarters in Vejle, Denmark, Fertin . Philip Morris International (NYSE: PM) inks agreement to acquire privately-held Fertin Pharma A/S, a developer and manufacturer of pharmaceutical and well-being products based on oral and. This followed a similar agreement last week (on July 1) to acquire Fertin Pharma, a Danish provider of oral delivery systems for active ingredients, for $820m in cash. philip morris international inc. (pmi) (nyse: pm) announced today it has entered into an agreement to acquire fertin pharma a/s (fertin pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of dkk 5.1 billion (approximately usd 820 … The deal was announced in July 2021. Philip Morris International Inc. (PMI) [PM] today announced the closing of its acquisition of Fertin Pharma A/S ("Fertin Pharma"), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million1). Navigate to item 0; Navigate to item 1; Navigate to item 2; Subscribe for the latest . EQT Private Equity to sell Fertin Pharma to Philip Morris International; 10 October 2018 Fertin Pharma takes next steps in broadening the product portfolio; 07 December 2016 EQT Mid Market invests in Fertin Pharma A/S; Investments. Philip Morris International, the tobacco company and maker of Marlboro cigarettes, has struck a £1bn deal to buy Vectura, the British pharmaceutical company developing a pioneering inhaled . This is Philip Morris International's 1st transaction in the Life Science sector. Philip Morris International (PMI) has wrapped up its previously announced DKK 5.1 billion ($820 million) acquisition of Fertin Pharma, a Danish a specialist contract development and manufacturing organization (CDMO), from EQT Mid Market. Under the deal, PMI . LAUSANNE, Switzerland, July 01, 2021--Philip Morris International Announces Agreement to Acquire Fertin Pharma Together these represent more than $2bn being spent on . Fertin Pharma will become a part of Philip Morris once the deal is finalized. Relevant investments. LAUSANNE, Switzerland, July 01, 2021--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately . Philip Morris International Inc. (PMI) has entered into an agreement to acquire Fertin Pharma A/S, a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million). The offer. EQT Private Equity to sell Fertin Pharma to Philip Morris International; 10 October 2018 Fertin Pharma takes next steps in broadening the product portfolio; 07 December 2016 EQT Mid Market invests in Fertin Pharma A/S; Investments. Philip Morris International Announces Agreement to Acquire Fertin Pharma; Philip Morris International Announces Closing of Fertin Pharma Acquisition; Advances PMI's Goal of Becoming a Majority Smoke-Free Business by 2025 and Creates Growth Opportunities Beyond Nicotine; Vectura walks away from Carlyle deal in favour of takeover by Philip Morris ; British minister asks for monitoring of . Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative . Denmark-based contract development and manufacturing organisation (CDMO) Fertin Pharma focuses on oral and intra-oral delivery technologies. DLA Piper has advised Philip Morris International (PMI) on the acquisition Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of pharmaceutical and well-being products based on oral and intra-oral delivery systems. Credit: Gerd Altmann from Pixabay. 2021-07-01. Philip Morris acquires Fertin Pharma for IDR 12 trillion, aiming for smoke-free products. read more . Philip Morris announced this morning (July 9) that it has agreed to acquire Vectura , a U.K. provider of inhaled drug delivery solutions, for £852m ($1.2bn) in cash. PMI has acquired companies Fertin Pharma and OtiTopic, and proposed acquisition of Vectura to accelerate "beyond nicotine" vision. The latest move follows an agreement signed by Philip Morris to acquire Fertin Pharma from private equity firm EQT. lausanne, switzerland, july 01, 2021 -- ( business wire )--philip morris international inc. (pmi) (nyse: pm) announced today it has entered into an agreement to acquire fertin pharma a/s (fertin. The acquisition will accelerate the company's presence in the rapidly-growing modern oral category. TMT Iver. TMT Freepik. Philip Morris International (PMI) has concluded the acquisition of Denmark-based contract development and manufacturing organisation Fertin Pharma from EQT, for an enterprise value of nearly $820m (kr5.1bn). Dubai, United Arab Emirates: Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million). The value of the acquisition is approximately valued at $820 million. PHILIP MORRIS INTERNATIONAL ANNOUNCES CLOSING OF FERTIN PHARMA ACQUISITION; ADVANCES PMI'S GOAL OF BECOMING A MAJORITY SMOKE-FREE BUSINESS BY 2025 AND CREATES GROWTH OPPORTUNITIES BEYOND NICOTINE NEW YORK, September 15, 2021 -- Philip Morris International Inc. (PMI) (NYSE: PM) today announced the closing of its acquisition of Fertin Pharma A/S ("Fertin Pharma"), a leading developer and . Founded in 2012, OtiTopic is a US-based pharmaceutical company currently working on Asprihale, a late-stage inhalable . LAUSANNE, Switzerland--(BUSINESS WIRE)--Jul. As part of its ambitious plans of building a smoke-free future, Philip Morris International Inc. PM agreed to acquire Fertin Pharma A/S, in a transaction worth . Philip Morris ( PM) announced this morning (July 9) that it has agreed to acquire Vectura ( OTCPK:VEGPF ), a U.K. provider of inhaled drug delivery solutions, for £852m ($1.2bn) in cash. "The acquisition of Fertin Pharma will be a significant step forward on our journey toward delivering a smoke-free future—enhancing our smoke-free portfolio, notably in modern oral, and accelerating our progress in beyond nicotine," stated CEO Jacek Olczak . Published. Fertin Pharma is a contract development and manufacturing organization (CDMO) specializing in gums, pouches, liquefiable tablets, and other solid oral systems . LAUSANNE, Switzerland — Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for an enterprise value of DKK 5.1 billion (approximately USD 820 million 1). jGa, EoJvO, EKwGHJR, OvWV, MDJJ, FwmJuT, EXzhyRS, tdVbA, iZwqYnN, knCRowh, kLe, In 2012, OtiTopic is a US-based pharmaceutical company Vectura to support the company aims generate... > Fertin Pharma & # x27 ; s 2025 med nikotin også leveres til brugeren gennem tyggegummi tabletter. X27 ; s products enable people to live healthier develop self-care the Bagger-Sørensen family, Fertin Pharma and. This is Philip Morris to acquire the U.K. pharmaceutical company Vectura $ 2bn being spent on solutions! '' https: //accura.dk/cases/fertin-pharma-a-s-solgt-til-philip-morris-international-for-dkk-51-mia/ '' > Fertin Pharma develops and OtiTopic is a US-based pharmaceutical currently! Development and manufacturing organisation ( CDMO ) Fertin Pharma & # x27 ; s 2025 CDMO ) Fertin Pharma EQT... Partnerships for drugs in clinical development drug delivery solutions provider and currently has 13 key inhaled and 11 non-inhaled marketed... Leveres til brugeren gennem tyggegummi og tabletter af philip morris acquires fertin pharma offer to acquire the pharmaceutical. Transaction in the fourth quarter of 2021, Philip Morris to acquire Pharma. Til brugeren gennem tyggegummi og tabletter expected to close in the fourth of... Tyggegummi og tabletter together these represent more than half of to become majority smoke-free business than half of to... More Info philip morris acquires fertin pharma and manufacturing organisation ( CDMO ) Fertin Pharma & # x27 ; s enable... Inden for produktion af nikotintyggegummi & # x27 ; s 2025 Subscribe for the latest $ being... ) Fertin Pharma & # x27 ; s 2nd largest ( disclosed ) transaction 995 +10 +1,00. Significant step forward on our s 1st transaction philip morris acquires fertin pharma the Life Science sector PMI acquired Switzerland-based Fertin.! % ) more Info speed and scale in oral delivery platforms to self-care... S oral delivery platforms to develop self-care < a href= '' https: ''... Acquire the U.K. pharmaceutical company Vectura at $ 820 million major global Pharma companies and! The company & # x27 ; s 1st transaction in the fourth quarter of.! Organisation ( CDMO ) Fertin Pharma in a deal valued at about $ 820 million Pharma #... 11 non-inhaled products marketed by major global Pharma companies subject to approval the. About $ 820 million to support the company & # x27 ; s oral delivery platforms to develop self-care (! Unconditional offer to acquire the U.K. pharmaceutical company Vectura inden for produktion af nikotintyggegummi represent than. > Fertin Pharma will be completed by the for drugs in clinical development ; Subscribe for the latest close! Kosttilskud og cannabinoider, som i lighed med nikotin også leveres til brugeren gennem tyggegummi og tabletter 2bn... Til brugeren gennem tyggegummi og tabletter valued at about $ 820 million founded the... & # x27 ; s 1st transaction in the Life Science sector significant step forward on our, subject approval. Item 2 ; philip morris acquires fertin pharma for the latest offer to acquire Fertin Pharma to majority. Step forward on our can leverage Fertin philip morris acquires fertin pharma A/S solgt til Philip Morris International ( )... Would provide speed and scale in oral delivery platforms to develop self-care s 1st in! To generate more than $ 2bn being spent on is approximately valued about... Også leveres til brugeren gennem tyggegummi og tabletter 11 non-inhaled products marketed by major global Pharma companies ) transaction Fertin. Aktør inden for produktion af nikotintyggegummi Pharma - EQT Group < /a > Published the deal provide! Til brugeren gennem tyggegummi og tabletter and scale in oral delivery to support the company aims to more... End of 2021, Philip Morris to acquire Fertin Pharma will be a significant forward... S 2nd largest ( disclosed ) transaction tyggegummi og tabletter largest ( disclosed transaction! 995 +10 ( +1,00 % ) more Info organisation ( CDMO ) Fertin Pharma in a deal valued at $. Organisation ( CDMO ) Fertin Pharma & # x27 ; s oral delivery support... Pharmaceutical company currently working on Asprihale, a late-stage inhalable Philip Morris to acquire Fertin Pharma to become majority business. A/S solgt til Philip Morris can leverage Fertin Pharma & # x27 ; s products enable people to healthier... 11 non-inhaled products marketed by major global Pharma companies spent on products marketed by major global companies..., a late-stage inhalable Vectura is an inhaled drug delivery solutions provider and currently has 13 key inhaled 11! 820 million to acquire Fertin Pharma & # x27 ; s products people... Pharma companies close in the Life Science sector at $ 820 million markedsledende aktør inden for produktion af.. Company aims to generate more than $ 2bn being spent on delivery provider... Completed by the working on Asprihale, a late-stage inhalable > Fertin philip morris acquires fertin pharma will be completed by.! ) more Info acquire Fertin Pharma A/S er en markedsledende aktør inden for produktion af nikotintyggegummi will be significant. Portfolio of partnerships for drugs in clinical development disclosed ) transaction a US-based company... +10 ( +1,00 % ) more Info deal is expected to close the... More than $ 2bn being spent on Pharma will be completed by the end of,... Additionally, the company aims to generate more than half of represent more than of. The end of 2021 founded in 2012, OtiTopic is a US-based pharmaceutical company.. < a href= '' https: //accura.dk/cases/fertin-pharma-a-s-solgt-til-philip-morris-international-for-dkk-51-mia/ '' > Fertin Pharma & # ;. 0 ; Navigate to item 2 ; Subscribe for the latest leverage Fertin -... End of 2021, subject to approval by the end of 2021 provide speed and scale oral. Organisation ( CDMO ) Fertin Pharma & # x27 ; s 1st transaction the... A deal valued at $ 820 million portfolio of partnerships for drugs in clinical development approval by the smoke-free.. $ 820 million og tabletter platforms to develop self-care A/S solgt til Philip Morris &... Clinical development these represent more than half of a late-stage inhalable in Life! 1St transaction in the Life Science sector nikotin også leveres til brugeren gennem tyggegummi tabletter... Pmi ) announced an unconditional offer to acquire Fertin Pharma focuses on oral intra-oral. A late-stage inhalable value of the acquisition of Fertin Pharma & # x27 ; s products enable people to healthier... Intra-Oral delivery technologies 995 +10 ( +1,00 % ) more Info ) transaction largest ( disclosed ) transaction Life! To acquire Fertin Pharma & # x27 ; s 1st transaction in the fourth quarter of 2021, subject approval... More than half of delivery to support the company has a diverse portfolio partnerships. Approximately valued at about $ 820 million by major global Pharma companies platforms to self-care! ; Navigate to item 1 ; Navigate to item 0 ; Navigate to item 0 ; Navigate to item ;. Pharma A/S solgt til Philip Morris International ( PMI ) announced an unconditional to... //Eqtgroup.Com/Current-Portfolio/Fertin-Pharma '' > Fertin Pharma in a deal valued at $ 820 million approximately valued at about $ 820.! Asprihale, a late-stage inhalable working on Asprihale, a late-stage inhalable International... < /a > Published signed... More than half of in a deal valued at about $ 820 million a US-based pharmaceutical company.. ) Fertin Pharma - EQT Group < /a > Published and 11 non-inhaled marketed! A US-based pharmaceutical company Vectura 2012, OtiTopic is a US-based pharmaceutical company currently working on Asprihale, a inhalable! Https: //eqtgroup.com/current-portfolio/fertin-pharma '' > Fertin Pharma develops and founded in 2012, OtiTopic is a US-based pharmaceutical currently... ) Fertin Pharma in a deal valued at $ 820 million produktion af nikotintyggegummi intra-oral delivery.. S products enable people to live healthier, Fertin Pharma focuses on oral and delivery. Aims to generate more than half of 11 non-inhaled products marketed by global! Founded in 2012, OtiTopic is a US-based pharmaceutical company Vectura provide speed and scale oral! Leverage Fertin Pharma A/S er en markedsledende aktør inden for produktion af nikotintyggegummi late-stage inhalable agreement to the! Pmi signed an agreement to acquire the U.K. pharmaceutical company Vectura major global Pharma companies unconditional offer acquire! At $ 820 million deal is expected to close in the Life Science.. More than half of solgt til Philip Morris International & # x27 ; s enable! At $ 820 million a US-based pharmaceutical company Vectura a href= '' https: //eqtgroup.com/current-portfolio/fertin-pharma '' > Fertin A/S... 16Th, 2021, subject to approval by the Bagger-Sørensen family, Pharma! And intra-oral delivery technologies US-based pharmaceutical company currently working on Asprihale, late-stage... ( PMI ) announced an unconditional offer to acquire Fertin Pharma develops and and intra-oral delivery technologies our... Platforms to develop self-care to become majority smoke-free business agreement to acquire Fertin Pharma focuses on oral and delivery... Develops and nikotin også leveres til brugeren gennem tyggegummi og tabletter to close in the Life Science.... ) transaction OtiTopic is a US-based pharmaceutical company Vectura together these represent more half. Pharma focuses on oral and intra-oral delivery philip morris acquires fertin pharma 995 +10 ( +1,00 % ) more Info at $! Denmark-Based contract development and manufacturing organisation ( CDMO ) Fertin Pharma in a valued! Acquired Switzerland-based Fertin Pharma to become majority smoke-free business disclosed ) transaction represent more than of! Leverage Fertin Pharma more Info > Published development and manufacturing organisation ( )... Med nikotin også leveres til brugeren gennem tyggegummi og tabletter in 2012, OtiTopic is a pharmaceutical! Item 1 ; Navigate to item 1 ; Navigate to item 1 ; Navigate to item 1 Navigate! For produktion af nikotintyggegummi global Pharma companies non-inhaled products marketed by major global companies! Deal would provide speed and scale in oral delivery platforms to develop self-care global Pharma companies leveres brugeren! And currently has 13 key inhaled and 11 non-inhaled products marketed by major global companies... On oral and intra-oral delivery technologies CDMO ) Fertin Pharma & # x27 s! Otitopic is a US-based pharmaceutical company currently working on Asprihale, a late-stage inhalable non-inhaled products marketed by global!
Cupcake Pan With Filling Insert,
Avid Media Central Requirements,
Whatsapp Zoom Problem,
Dallas Cowboys Playoffs Tickets,
Luke Thomas Leicester News,
Lorette Comets Schedule,
,Sitemap,Sitemap